Search research articles
Contact Us
Filters
Showing results (231-240 of 414) with videos related to
Page
of 42
Sort By:
American Heart Journal
|
October 23, 2024
Brief report: U.S. trends in use of colchicine by cardiologists and other specialties, 2018 to 2024
Michael Khorsandi, Omar Mhaimeed, Omar Dzaye, et al.
JAMA Network Open
|
June 8, 2019
Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017
Jenny S Guadamuz, G Caleb Alexander, Tanya Chaudhri, et al.
Archives of Internal Medicine
|
April 14, 2010
Importance of distinguishing supported and unsupported off-label drug use
Surrey M Walton, Glen T Schumock, G Caleb Alexander, et al.
Journal of General Internal Medicine
|
July 10, 2004
Barriers to patient-physician communication about out-of-pocket costs
G Caleb Alexander, Lawrence P Casalino, Chien-Wen Tseng, et al.
Drug and Alcohol Dependence
|
December 5, 2020
Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011-2016
Ju Nyeong Park, Emaan Rashidi, Kathryn Foti, et al.
Archives of Internal Medicine
|
January 13, 2010
Impact of FDA black box advisory on antipsychotic medication use
E Ray Dorsey, Atonu Rabbani, Sarah A Gallagher, et al.
Journal of Comparative Effectiveness Research
|
February 22, 2018
Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion
Ernest Law, Rachel Harrington, G Caleb Alexander, et al.
JAMA Internal Medicine
|
December 9, 2014
Prescription drug abuse: a national survey of primary care physicians
Catherine S Hwang, Lydia W Turner, Stefan P Kruszewski, et al.
JAMA Psychiatry
|
January 15, 2015
Emergency department visits by children and adolescents for antipsychotic drug adverse events
Lee M Hampton, Matthew Daubresse, Hsien-Yen Chang, et al.
Plos One
|
August 17, 2017
The availability of pharmacies in the United States: 2007-2015
Dima Mazen Qato, Shannon Zenk, Jocelyn Wilder, et al.
Page
of 42
Search research articles
Search
Showing results (231-240 of 414) with videos related to
Sort By:
Page
of 42
American Heart Journal
|
October 23, 2024
Brief report: U.S. trends in use of colchicine by cardiologists and other specialties, 2018 to 2024
Michael Khorsandi, Omar Mhaimeed, Omar Dzaye, et al.
JAMA Network Open
|
June 8, 2019
Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017
Jenny S Guadamuz, G Caleb Alexander, Tanya Chaudhri, et al.
Archives of Internal Medicine
|
April 14, 2010
Importance of distinguishing supported and unsupported off-label drug use
Surrey M Walton, Glen T Schumock, G Caleb Alexander, et al.
Journal of General Internal Medicine
|
July 10, 2004
Barriers to patient-physician communication about out-of-pocket costs
G Caleb Alexander, Lawrence P Casalino, Chien-Wen Tseng, et al.
Drug and Alcohol Dependence
|
December 5, 2020
Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011-2016
Ju Nyeong Park, Emaan Rashidi, Kathryn Foti, et al.
Archives of Internal Medicine
|
January 13, 2010
Impact of FDA black box advisory on antipsychotic medication use
E Ray Dorsey, Atonu Rabbani, Sarah A Gallagher, et al.
Journal of Comparative Effectiveness Research
|
February 22, 2018
Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion
Ernest Law, Rachel Harrington, G Caleb Alexander, et al.
JAMA Internal Medicine
|
December 9, 2014
Prescription drug abuse: a national survey of primary care physicians
Catherine S Hwang, Lydia W Turner, Stefan P Kruszewski, et al.
JAMA Psychiatry
|
January 15, 2015
Emergency department visits by children and adolescents for antipsychotic drug adverse events
Lee M Hampton, Matthew Daubresse, Hsien-Yen Chang, et al.
Plos One
|
August 17, 2017
The availability of pharmacies in the United States: 2007-2015
Dima Mazen Qato, Shannon Zenk, Jocelyn Wilder, et al.
Page
of 42